Literature DB >> 2885414

Role of endogenous histamine in postanaphylactic phase of allergic inflammation in rats.

N Hirasawa, K Ohuchi, M Watanabe, S Tsurufuji.   

Abstract

Role of endogenous histamine in postanaphylactic phase of allergic inflammation was examined by using a rat model of allergic inflammation of air pouch type. Histamine in the exudate revealed a biphasic increase. The anaphylactic increase was followed by rapid decrease and then by a gradual rising in postanaphylactic phase with the maximum attained around 24 hr after the antigenic challenge. It again decreased gradually. The histamine increase in the postanaphylactic phase was accompanied by the increase of histidine decarboxylase activity in inflammatory tissues. Local administration of pyrilamine, an H1 antagonist, together with either methysergide, a serotonin antagonist, or cimetidine, an H2 antagonist, was unable to inhibit vascular permeability response in the postanaphylactic phase. When histaminase was administered locally in the postanaphylactic phase to reduce histamine in the exudate, neutrophil accumulation in the exudate was enhanced without any change in exudate accumulation. Enhancement of the neutrophil accumulation was also inducible with local administration of cimetidine but not with pyrilamine. Local administration of histamine inhibited the neutrophil accumulation dose-dependently. These results suggest that endogenous histamine released in the postanaphylactic phase contributes to downward regulation of neutrophil accumulation in the inflammatory site without affecting the vascular permeability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885414

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Downward regulation of neutrophil infiltration by endogenous histamine without affecting vascular permeability responses in air-pouch-type carrageenin inflammation in rats.

Authors:  N Hirasawa; M Watanabe; S Mue; S Tsurufuji; K Ohuchi
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Changes in histamine and prostaglandins in acute inflammatory air pouch in mice.

Authors:  Y M Sin; C H Tan; S F Chan
Journal:  Agents Actions       Date:  1989-08

3.  Pharmacological investigation of acute cellular accumulation in immunological air pouch inflammation.

Authors:  P Hambleton; P Miller
Journal:  Agents Actions       Date:  1989-08

4.  Antisera against rat recombinant histidine decarboxylase: immunocytochemical studies in different species.

Authors:  C Dartsch; F Sundler; L Persson
Journal:  Histochem J       Date:  1999-08

5.  Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats.

Authors:  J Tanabe; M Watanabe; S Kondoh; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

6.  Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice.

Authors:  Noriyasu Hirasawa; Hiroshi Ohtsu; Takehiko Watanabe; Kazuo Ohuchi
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

7.  Analysis of histamine-producing cells at the late phase of allergic inflammation in rats.

Authors:  M Shiraishi; N Hirasawa; S Oikawa; Y Kobayashi; K Ohuchi
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

8.  Increase in histamine production by inflammatory exudate in the chronic phase of allergic inflammation in rats.

Authors:  N Hirasawa; M Shiraishi; S Oikawa; S Mue; K Ohuchi
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

9.  A23187-induced pulmonary gas trapping and inflammation in the guinea pig.

Authors:  P W Stengel; G D Williams; S A Silbaugh
Journal:  Agents Actions       Date:  1991-03

10.  Suppression of peritoneal thickening by histamine in a mouse model of peritoneal scraping.

Authors:  Keyue Liu; Toshihiro Yorozuya; Naoto Adachi; Atsuko Motoki; Kanji Ninomiya; Hisao Mabuchi; Noriyuki Iwamoto; Masahiro Nishibori
Journal:  Clin Exp Nephrol       Date:  2014-09-06       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.